AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
-1.15%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$14.4B
AUM Growth
+$334M
(+2.4%)
Cap. Flow
+$619M
Cap. Flow
% of AUM
4.29%
Top 10 Holdings %
Top 10 Hldgs %
50.45%
Holding
913
New
139
Increased
302
Reduced
176
Closed
73
Top Buys
| 1 |
NGL Energy Partners
NGL
|
$130M |
| 2 |
ETP
Energy Transfer Partners, L.P.
ETP
|
$116M |
| 3 |
ANDX
Andeavor Logistics LP
ANDX
|
$65.9M |
| 4 |
Helmerich & Payne
HP
|
$53.7M |
| 5 |
Kohl's
KSS
|
$52.2M |
Top Sells
| 1 |
T Rowe Price
TROW
|
$57.9M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$53.8M |
| 3 |
Garmin
GRMN
|
$51.5M |
| 4 |
AbbVie
ABBV
|
$51.4M |
| 5 |
Chevron
CVX
|
$51.3M |
Sector Composition
| 1 | Energy | 58.22% |
| 2 | Healthcare | 2.73% |
| 3 | Financials | 2.71% |
| 4 | Materials | 2.68% |
| 5 | Consumer Discretionary | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
SPDR Bloomberg High Yield Bond ETF
JNK
$8.1B
| $3.85M | 0.03% |
34,907
-100,562
| -74% | -$11.1M |
|
|
GWPH
152
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.7M | 0.03% |
28,041
+3,120
| +13% | +$412K |
|
|
CLVS
153
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.69M | 0.03% |
+54,314
| New | +$3.69M |
|
154
McEwen Inc.
MUX
$734M
| $3.58M | 0.02% |
156,862
+35,251
| +29% | +$804K |
|
155
Plains GP Holdings
PAGP
$3.64B
| $3.57M | 0.02% |
162,730
+18,654
| +13% | +$409K |
|
|
PTLA
156
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.52M | 0.02% |
72,306
+15,518
| +27% | +$755K |
|
157
Liberty Media Series A
FWONA
$22.6B
| $3.5M | 0.02% |
111,654
+26,932
| +32% | +$844K |
|
158
Gold Fields
GFI
$30.8B
| $3.47M | 0.02% |
807,453
-214,103
| -21% | -$921K |
|
|
Y
159
DELISTED
Alleghany Corporation
Y
| $3.41M | 0.02% |
+5,719
| New | +$3.41M |
|
|
LSXMA
160
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $3.29M | 0.02% |
114,745
+19,447
| +20% | +$557K |
|
161
Ligand Pharmaceuticals
LGND
$3.25B
| $3.2M | 0.02% |
37,488
+4,461
| +14% | +$381K |
|
162
Halozyme
HALO
$8.76B
| $3.2M | 0.02% |
157,748
+17,984
| +13% | +$364K |
|
163
Meta Platforms (Facebook)
META
$1.89T
| $3.14M | 0.02% |
17,790
+6,201
| +54% | +$1.09M |
|
164
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$13.7B
| $3.09M | 0.02% |
30,408
+75
| +0.2% | +$7.62K |
|
165
Compass Diversified
CODI
$548M
| $3.08M | 0.02% |
181,950
+2,550
| +1% | +$43.2K |
|
166
Agios Pharmaceuticals
AGIO
$2.09B
| $3.05M | 0.02% |
53,416
+5,943
| +13% | +$340K |
|
|
AUY
167
DELISTED
Yamana Gold, Inc.
AUY
| $2.96M | 0.02% |
947,794
-351,573
| -27% | -$1.1M |
|
168
FTAI Aviation
FTAI
$15.8B
| $2.85M | 0.02% |
167,336
+45,714
| +38% | +$778K |
|
169
Simon Property Group
SPG
$59.5B
| $2.84M | 0.02% |
16,519
+274
| +2% | +$47.1K |
|
|
ARRY
170
DELISTED
Array Biopharma Inc
ARRY
| $2.8M | 0.02% |
218,328
+49,485
| +29% | +$633K |
|
|
LOXO
171
DELISTED
Loxo Oncology, Inc
LOXO
| $2.79M | 0.02% |
33,080
+3,679
| +13% | +$310K |
|
|
IMMU
172
DELISTED
Immunomedics Inc
IMMU
| $2.72M | 0.02% |
+168,456
| New | +$2.72M |
|
173
JPMorgan Chase
JPM
$809B
| $2.72M | 0.02% |
25,403
+11,147
| +78% | +$1.19M |
|
174
Emergent Biosolutions
EBS
$404M
| $2.7M | 0.02% |
58,094
+5,283
| +10% | +$246K |
|
175
NovaGold Resources
NG
$2.75B
| $2.67M | 0.02% |
679,490
-84,362
| -11% | -$331K |
|